公司資料
Bausch Health 股價、新聞與催化劑
- 股票代碼:
- BHC
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- Canada and listed in the U
股票表現
5.80 USD (+1.22%)
收盤價
最後更新: 2026年10月2日
1.87B USD
市值
股價為何變動
截至 2026年10月2日，BHC 上漲 1.22%，收於 $5.80。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Bausch Health is a diversified healthcare company with exposure to branded pharmaceuticals, specialty products, and medical aesthetics. Its business has been shaped by portfolio management, debt structure, and cash-flow durability.
所在地與產業分類
Bausch Health is headquartered in Canada and listed in the U.S. market. It sits in diversified healthcare and specialty pharma rather than pure biotech.
商業模式特徵
The company depends on product sales, portfolio stabilization, and balance-sheet management. Investors focus on debt reduction, commercial execution, and the durability of its various franchises.
生技產業定位
Bausch Health sits outside biotech proper but remains highly relevant to healthcare investors. Its story is more about leverage, commercial execution, and portfolio value than about classic R&D catalysts.
未來催化劑
- Bausch Health’s catalysts are debt reduction, portfolio execution, and any update that clarifies the company’s path back to a cleaner earnings profile. The stock will care most about balance-sheet progress.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。